Edinburgh-based Craneware, a provider of software for the US healthcare market, said its revenues for the six months ended December 31, 2022, increased 6% to $84.7 million and profit before tax slipped to $5.2 million from $6.2 million.

Total bank debt fell to $107.9 million from $114.6 million.

Interim dividend is unchanged at 12.5p.

Craneware CEO Keith Neilson said: “We remain acutely conscious of the ongoing challenges faced by our customers and partners, in particular the impact of inflationary pressures and staffing shortages.

“The pressures they are experiencing strengthens our commitment to providing the tools to more accurately manage their operations and finances, as we seek to transformthe business of US healthcare together.

“We are financially strong, with healthy cash reserves and a solid foundation of Annual Recurring Revenue.

“This, combined with our market leading solutions, breadth of customer base, the scale of data flowing through our platform and the industry drive to achieve better value in healthcare, means we remain confident in our ability to deliver acceleration in our growth rates as the current pressures within the US healthcare market abate.”